We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
(+12%)
Cap. Flow
+$73.4M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$48.8M |
| 2 |
Comcast
CMCSA
|
+$46.9M |
| 3 |
Avery Dennison
AVY
|
+$38.5M |
| 4 |
Middleby
MIDD
|
+$33M |
| 5 |
LKQ Corp
LKQ
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$63.1M |
| 2 |
T. Rowe Price
TROW
|
+$47.7M |
| 3 |
Intuitive Surgical
ISRG
|
+$39M |
| 4 |
Plains All American Pipeline
PAA
|
+$39M |
| 5 |
Sherwin-Williams
SHW
|
+$38.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.65% |
| 2 | Financials | 14.81% |
| 3 | Industrials | 14.31% |
| 4 | Technology | 11.57% |
| 5 | Energy | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Caterpillar
CAT
$336B
| $623K | 0.01% |
7,467
-1,477
| -17% | -$125K |
2013 Q2
1 quarter
|
|
|
BBBY
277
DELISTED
Bed Bath & Beyond Inc
BBBY
| $619K | 0.01% |
8,000
+3,000
| +60% | +$225K |
2013 Q2
1 quarter
|
|
278
Kayne Anderson Energy Infrastructure Fund
KYN
$2.39B
| $612K | 0.01% |
17,083
+6
| +0% | +$216 |
2013 Q2
1 quarter
|
|
279
Cognizant
CTSH
$29.7B
| $603K | 0.01% |
14,692
| – | – |
2013 Q2
1 quarter
|
|
280
Fifth Third Bancorp
FITB
$45.7B
| $603K | 0.01% |
33,381
+1,795
| +6% | +$33.8K |
2013 Q2
1 quarter
|
|
|
281
Intuitive Surgical
ISRG
$151B
| $593K | 0.01% |
14,184
-883,278
| -98% | -$39M |
2013 Q2
1 quarter
|
|
|
KRFT
282
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $585K | 0.01% |
11,142
+73
| +0.7% | +$4K |
2013 Q2
1 quarter
|
|
283
Aon
AON
$62.1B
| $578K | 0.01% |
7,764
+1,298
| +20% | +$89.1K |
2013 Q2
1 quarter
|
|
284
Lockheed Martin
LMT
$127B
| $564K | 0.01% |
4,418
+13
| +0.3% | +$1.58K |
2013 Q2
1 quarter
|
|
|
PNY
285
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $562K | 0.01% |
17,100
| – | – |
2013 Q2
1 quarter
|
|
286
DELISTED
Du Pont De Nemours E I
DD
| $559K | 0.01% |
10,054
-498
| -5% | -$27.2K |
2013 Q2
1 quarter
|
|
287
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $541K | 0.01% |
12,125
-2,565
| -17% | -$118K |
2013 Q2
1 quarter
|
|
288
State Street
STT
$45.5B
| $537K | 0.01% |
8,165
-2,566
| -24% | -$176K |
2013 Q2
1 quarter
|
|
|
AGN
289
DELISTED
Allergan plc
AGN
| $532K | 0.01% |
3,695
| – | – |
2013 Q2
1 quarter
|
|
290
iShares Preferred and Income Securities ETF
PFF
$12B
| $529K | 0.01% |
13,912
+1,580
| +13% | +$60.4K |
2013 Q2
1 quarter
|
|
291
Liberty Media Corporation Series A Common Stock
FWONA
$20.9B
| $524K | 0.01% |
20,034
| – | – |
2013 Q2
1 quarter
|
|
|
FRC
292
DELISTED
First Republic Bank
FRC
| $517K | 0.01% |
11,086
+345
| +3% | +$15.1K |
2013 Q2
1 quarter
|
|
293
Unilever
UL
$142B
| $515K | 0.01% |
11,871
-317
| -3% | -$14.4K |
2013 Q2
1 quarter
|
|
294
Celanese
CE
$5.21B
| $512K | 0.01% |
+9,700
| New | +$475K |
2013 Q3
0 quarters
|
|
295
iShares Russell 1000 Value ETF
IWD
$83.6B
| $510K | 0.01% |
5,921
-1,772
| -23% | -$154K |
2013 Q2
1 quarter
|
|
|
TAT
296
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $504K | 0.01% |
60,000
+50,000
| +500% | +$416K |
2013 Q2
1 quarter
|
|
297
Bank of America
BAC
$358B
| $493K | 0.01% |
35,712
+516
| +1% | +$7.37K |
2013 Q2
1 quarter
|
|
298
NCR Voyix
VYX
$1.05B
| $492K | 0.01% |
20,230
-163
| -0.8% | -$3.65K |
2013 Q2
1 quarter
|
|
299
General Mills
GIS
$17.7B
| $488K | 0.01% |
10,193
| – | – |
2013 Q2
1 quarter
|
|
300
Exelon
EXC
$44.8B
| $486K | 0.01% |
22,997
+5,574
| +32% | +$122K |
2013 Q2
1 quarter
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
- Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
- Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
- Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
- Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
- Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
- Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.
Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.